Literature DB >> 16052555

Solution behavior of IFN-beta-1a: an empirical phase diagram based approach.

Haihong Fan1, John Ralston, Mary Dibiase, Eric Faulkner, C Russell Middaugh.   

Abstract

An empirical phase diagram approach has been developed as a practical tool to aid macromolecular preformulation/formulation studies. This method employs an eigenvector based procedure to visualize and interpret complex data sets. Human Inteferon-beta-1a, an important therapeutic protein, was used to further develop the method and test its utility. The protein was characterized in solution as a function of pH (2-8), temperature (10 degrees C-85 degrees C) and ionic strength (I = 0.1 and 1.0) using intrinsic and ANS fluorescence, Far-UV circular dichroism (Far-UV CD), Fourier Transform Infrared spectroscopy (FTIR) and derivative UV absorbance spectroscopies, as well as differential scanning calorimetry (DSC) to supplement spectroscopic thermal stability studies. Derivative UV absorbance data were initially used to construct a pH-temperature phase diagram at each ionic strength. Three distinctive phases at I = 0.1 and two major phases at I = 1.0 were identified corresponding to different conformation/aggregation states of the protein. For the first time, heterogeneous data sets (i.e., data from different techniques) including Far-UV CD, fluorescence and UV absorbance results were used to generate empirical phase diagrams. Results from different data sets are compared; precautions in applying the method and its overall utility are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052555     DOI: 10.1002/jps.20410

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Improved data visualization techniques for analyzing macromolecule structural changes.

Authors:  Jae Hyun Kim; Vidyashankara Iyer; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

Review 2.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

3.  Probing residue-specific interactions in the stabilization of proteins using high-resolution NMR: a study of disulfide bond compensation.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

4.  Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

Authors:  Miranda M C van Beers; Melody Sauerborn; Francesca Gilli; Vera Brinks; Huub Schellekens; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-05-25       Impact factor: 4.200

5.  Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.

Authors:  Joshua D Ramsey; Michelle L Gill; Tim J Kamerzell; E Shane Price; Sangeeta B Joshi; Steven M Bishop; Cynthia N Oliver; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2009-07       Impact factor: 3.534

6.  Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol- maleimide chemistry.

Authors:  Jianxin Guo; Sandeep Kumar; Amarnauth Prashad; Jason Starkey; Satish K Singh
Journal:  Pharm Res       Date:  2014-01-24       Impact factor: 4.200

7.  Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein.

Authors:  Aaron P Markham; Zane A Jaafar; Kyle E Kemege; C Russell Middaugh; P Scott Hefty
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

8.  Evaluation of the physical stability of the EC5 domain of E-cadherin: effects of pH, temperature, ionic strength, and disulfide bonds.

Authors:  Kai Zheng; C Russell Middaugh; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

9.  Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties.

Authors:  Kyoung Song; In-Soo Yoon; Nam Ah Kim; Dong-Hwan Kim; Jongmin Lee; Hee Jung Lee; Saehyung Lee; Sunghyun Choi; Min-Koo Choi; Ha Hyung Kim; Seong Hoon Jeong; Woo Sung Son; Dae-Duk Kim; Young Kee Shin
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

10.  Comparative Toxicity of Interferon Beta-1a Impurities of Heavy Metal Ions.

Authors:  Dmitriy Berillo
Journal:  Medicina (Kaunas)       Date:  2022-03-23       Impact factor: 2.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.